zafirlukast

(redirected from Accolate)
Also found in: Medical.
Related to Accolate: Accutane, zafirlukast, Singulair

za·fir·lu·kast

 (zə-fîr′lo͞o-kăst′)
n.
A drug, C31H33N3O6S, that acts as a leukotriene receptor antagonist, reduces the inflammatory process, and is used in the treatment of asthma.

[zafir- (perhaps ultimately alteration of sulfonyl) + -lukast, leukotriene receptor antagonist suff. (from rearrangement of (anti)as(thmatic) l(e)uk(otriene receptor antagonis)t).]
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.
Translations

zafirlukast

n zafirlukast m
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
Mentioned in ?
References in periodicals archive ?
He has had significant involvement in the development and/or global registration of many drugs including Krystexxa, Onivyde, Oncaspar, Velcade, Alimta, DOXIL and Accolate.
The company, with outlets in Dunfermline and Stirling, have been awarded the renowned Platinum Prestige Award by Kia Motors Corporation, the highest accolate of its kind.
An oral version of the drug marketed as a generic and by Astra Zeneca as Accolate', is a first-in-class anti- leukotriene and treatment for asthma.
Antihistamines, cortisone, dexamethasone, hydrocortisone, epinephrine, theophylline, cromolyn sodium, and antileukotrienes, such as Singulair or Accolate, are FDA approved for treatment of allergic diseases.
Effect of zafirlukast (Accolate) on cellular mediators of inflammation: Bronchoalveolar lavage fluid findings after segmental antigen challenge.
FDA-approved leukotriene inhibitors include montelukast (Singulair and generic) and zafirlukast (Accolate), both of which are prescription tablets.
Medications commonly used to treat asthma include corticosteroids (inhaled and oral), leukotriene antagonists (Singulair, Accolate, and Zyflo), theophylline, bronchodilators (both short- and long-acting), and xolair (Omalizumab).
We shall wax romantic no longer and present to you which nominees deserve the accolate and which candidate will most likely grab that tiny bald golden man.
LTRAs are sold under the brand names Singulair (montelukast) and Accolate (zafirlukast).
LTRAs, sold under the brand names Singulair and Accolate, have long been available as alternative treatments to ward off asthma attacks.
LTRAs, sold under the brand names "Singulair" (montelukast) and "Accolate" (zafirlukast), have long been on the market as an alternative to the steroid inhalers commonly used by asthmatics to ward off attacks.
In November 2010, Par Pharmaceutical began shipping 10mg and 20mg strengths of a generic version of AstraZeneca's Accolate [R] (zafirlukast) tablets.